Drug Manufacturers - Specialty & Generic
Compare Stocks
5 / 10Stock Comparison
HLN vs CL vs PG vs CHD vs KMB
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Household & Personal Products
Household & Personal Products
HLN vs CL vs PG vs CHD vs KMB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Household & Personal Products | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $41.45B | $70.09B | $341.30B | $22.24B | $33.05B |
| Revenue (TTM) | $22.01B | $20.38B | $86.72B | $6.21B | $16.54B |
| Net Income (TTM) | $3.18B | $2.13B | $12.72B | $733M | $2.12B |
| Gross Margin | 63.9% | 60.1% | 50.3% | 45.1% | 35.9% |
| Operating Margin | 21.4% | 21.3% | 23.2% | 17.3% | 13.3% |
| Forward P/E | 22.2x | 22.9x | 21.1x | 25.0x | 13.2x |
| Total Debt | $8.59B | $7.99B | $35.46B | $2.21B | $7.17B |
| Cash & Equiv. | $1.32B | $1.29B | $9.56B | $409M | $688M |
HLN vs CL vs PG vs CHD vs KMB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | May 26 | Return |
|---|---|---|---|
| Haleon plc (HLN) | 100 | 132.4 | +32.4% |
| Colgate-Palmolive C… (CL) | 100 | 110.9 | +10.9% |
| The Procter & Gambl… (PG) | 100 | 105.1 | +5.1% |
| Church & Dwight Co.… (CHD) | 100 | 106.7 | +6.7% |
| Kimberly-Clark Corp… (KMB) | 100 | 75.5 | -24.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HLN vs CL vs PG vs CHD vs KMB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HLN has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.06, Low D/E 52.2%, current ratio 0.92x
- PEG 2.63 vs PG's 3.78
- Beta 0.06, yield 1.9%, current ratio 0.92x
- Lower P/E (22.2x vs 25.0x)
CL is the clearest fit if your priority is efficiency.
- 12.5% ROA vs CHD's 8.2%, ROIC 43.4% vs 13.9%
PG is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 119.3% 10Y total return vs HLN's 31.7%
- 14.7% margin vs CL's 10.5%
- 2.8% yield, 36-year raise streak, vs KMB's 5.0%
CHD ranks third and is worth considering specifically for growth exposure.
- Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
- 1.6% revenue growth vs KMB's -14.2%
- +3.4% vs KMB's -21.7%
Among these 5 stocks, KMB doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.6% revenue growth vs KMB's -14.2% | |
| Value | Lower P/E (22.2x vs 25.0x) | |
| Quality / Margins | 14.7% margin vs CL's 10.5% | |
| Stability / Safety | Beta 0.06 vs KMB's 0.14, lower leverage | |
| Dividends | 2.8% yield, 36-year raise streak, vs KMB's 5.0% | |
| Momentum (1Y) | +3.4% vs KMB's -21.7% | |
| Efficiency (ROA) | 12.5% ROA vs CHD's 8.2%, ROIC 43.4% vs 13.9% |
HLN vs CL vs PG vs CHD vs KMB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HLN vs CL vs PG vs CHD vs KMB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PG leads in 1 of 6 categories
KMB leads 1 • CL leads 1 • HLN leads 0 • CHD leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 14.0x CHD's $6.2B. Profitability is closely matched — net margins range from 14.7% (PG) to 10.5% (CL). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $22.0B | $20.4B | $86.7B | $6.2B | $16.5B |
| EBITDAEarnings before interest/tax | $5.3B | $3.9B | $21.9B | $1.3B | $2.8B |
| Net IncomeAfter-tax profit | $3.2B | $2.1B | $12.7B | $733M | $2.1B |
| Free Cash FlowCash after capex | $3.1B | $3.6B | $15.0B | $1.1B | $2.6B |
| Gross MarginGross profit ÷ Revenue | +63.9% | +60.1% | +50.3% | +45.1% | +35.9% |
| Operating MarginEBIT ÷ Revenue | +21.4% | +21.3% | +23.2% | +17.3% | +13.3% |
| Net MarginNet income ÷ Revenue | +14.5% | +10.5% | +14.7% | +11.8% | +12.8% |
| FCF MarginFCF ÷ Revenue | +14.2% | +17.8% | +17.3% | +17.2% | +15.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.4% | +5.8% | +7.4% | +0.1% | -14.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +18.8% | -105.1% | +5.8% | +2.2% | +17.6% |
Valuation Metrics
KMB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, KMB trades at a 51% valuation discount to CL's 33.2x P/E. Adjusting for growth (PEG ratio), HLN offers better value at 2.25x vs PG's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $41.4B | $70.1B | $341.3B | $22.2B | $33.0B |
| Enterprise ValueMkt cap + debt − cash | $51.3B | $76.8B | $367.2B | $24.0B | $39.5B |
| Trailing P/EPrice ÷ TTM EPS | 19.01x | 33.22x | 22.44x | 31.09x | 16.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.22x | 22.88x | 21.14x | 25.01x | 13.24x |
| PEG RatioP/E ÷ EPS growth rate | 2.25x | — | 4.01x | — | — |
| EV / EBITDAEnterprise value multiple | 13.62x | 15.43x | 15.76x | 18.14x | 12.73x |
| Price / SalesMarket cap ÷ Revenue | 2.83x | 3.44x | 4.05x | 3.59x | 1.92x |
| Price / BookPrice ÷ Book value/share | 1.87x | 194.13x | 6.86x | 5.73x | 20.07x |
| Price / FCFMarket cap ÷ FCF | 15.47x | 19.29x | 24.30x | 20.35x | 20.16x |
Profitability & Efficiency
CL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $17 for CHD. HLN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs KMB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +19.9% | +2.5% | +23.8% | +17.4% | +131.7% |
| ROA (TTM)Return on assets | +10.0% | +12.5% | +10.0% | +8.2% | +12.5% |
| ROICReturn on invested capital | +7.6% | +43.4% | +20.1% | +13.9% | +23.3% |
| ROCEReturn on capital employed | +8.6% | +41.6% | +23.0% | +14.4% | +25.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.52x | 21.88x | 0.68x | 0.55x | 4.34x |
| Net DebtTotal debt minus cash | $7.3B | $6.7B | $25.9B | $1.8B | $6.5B |
| Cash & Equiv.Liquid assets | $1.3B | $1.3B | $9.6B | $409M | $688M |
| Total DebtShort + long-term debt | $8.6B | $8.0B | $35.5B | $2.2B | $7.2B |
| Interest CoverageEBIT ÷ Interest expense | 7.80x | 12.37x | 487.21x | 15.59x | 9.67x |
Total Returns (Dividends Reinvested)
Evenly matched — CL and CHD each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLN five years ago would be worth $13,169 today (with dividends reinvested), compared to $9,117 for KMB. Over the past 12 months, CHD leads with a +3.4% total return vs KMB's -21.7%. The 3-year compound annual growth rate (CAGR) favors CL at 5.0% vs KMB's -7.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.6% | +13.8% | +4.5% | +14.0% | -0.6% |
| 1-Year ReturnPast 12 months | -11.7% | -1.6% | -5.6% | +3.4% | -21.7% |
| 3-Year ReturnCumulative with dividends | +10.4% | +15.7% | +1.9% | +0.7% | -21.0% |
| 5-Year ReturnCumulative with dividends | +31.7% | +18.2% | +22.4% | +13.7% | -8.8% |
| 10-Year ReturnCumulative with dividends | +31.7% | +47.0% | +119.3% | +113.6% | +12.2% |
| CAGR (3Y)Annualised 3-year return | +3.4% | +5.0% | +0.6% | +0.2% | -7.6% |
Risk & Volatility
Evenly matched — CL and CHD each lead in 1 of 2 comparable metrics.
Risk & Volatility
CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than KMB's 0.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs KMB's 69.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.06x | -0.00x | 0.10x | 0.14x | 0.14x |
| 52-Week HighHighest price in past year | $11.42 | $99.33 | $170.99 | $106.04 | $144.31 |
| 52-Week LowLowest price in past year | $8.71 | $74.55 | $137.62 | $81.33 | $92.42 |
| % of 52W HighCurrent price vs 52-week peak | +81.5% | +87.9% | +85.4% | +88.5% | +69.0% |
| RSI (14)Momentum oscillator 0–100 | 36.0 | 58.1 | 53.7 | 49.1 | 53.7 |
| Avg Volume (50D)Average daily shares traded | 8.0M | 5.6M | 7.2M | 1.8M | 4.7M |
Analyst Outlook
Evenly matched — PG and KMB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HLN as "Buy", CL as "Hold", PG as "Buy", CHD as "Buy", KMB as "Hold". Consensus price targets imply 10.8% upside for PG (target: $162) vs 6.1% for CHD (target: $100). For income investors, KMB offers the higher dividend yield at 5.01% vs CHD's 1.25%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $10.20 | $93.70 | $161.88 | $99.60 | $110.00 |
| # AnalystsCovering analysts | 4 | 45 | 52 | 34 | 31 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +2.6% | +2.8% | +1.3% | +5.0% |
| Dividend StreakConsecutive years of raises | 2 | 5 | 36 | 23 | 27 |
| Dividend / ShareAnnual DPS | $0.13 | $2.25 | $4.02 | $1.18 | $4.98 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +1.7% | +1.9% | +4.0% | +0.4% |
PG leads in 1 of 6 categories (Income & Cash Flow). KMB leads in 1 (Valuation Metrics). 3 tied.
HLN vs CL vs PG vs CHD vs KMB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HLN or CL or PG or CHD or KMB a better buy right now?
For growth investors, Church & Dwight Co.
, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -14. 2% for Kimberly-Clark Corporation (KMB). Kimberly-Clark Corporation (KMB) offers the better valuation at 16. 4x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HLN or CL or PG or CHD or KMB?
On trailing P/E, Kimberly-Clark Corporation (KMB) is the cheapest at 16.
4x versus Colgate-Palmolive Company at 33. 2x. On forward P/E, Kimberly-Clark Corporation is actually cheaper at 13. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haleon plc wins at 2. 63x versus The Procter & Gamble Company's 3. 78x.
03Which is the better long-term investment — HLN or CL or PG or CHD or KMB?
Over the past 5 years, Haleon plc (HLN) delivered a total return of +31.
7%, compared to -8. 8% for Kimberly-Clark Corporation (KMB). Over 10 years, the gap is even starker: PG returned +119. 3% versus KMB's +12. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HLN or CL or PG or CHD or KMB?
By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.
00β versus Kimberly-Clark Corporation's 0. 14β — meaning KMB is approximately -3332% more volatile than CL relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.
05Which is growing faster — HLN or CL or PG or CHD or KMB?
By revenue growth (latest reported year), Church & Dwight Co.
, Inc. (CHD) is pulling ahead at 1. 6% versus -14. 2% for Kimberly-Clark Corporation (KMB). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -25. 1% for Colgate-Palmolive Company. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HLN or CL or PG or CHD or KMB?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 10. 5% for Colgate-Palmolive Company — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 14. 5% for KMB. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HLN or CL or PG or CHD or KMB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Haleon plc (HLN) is the more undervalued stock at a PEG of 2. 63x versus The Procter & Gamble Company's 3. 78x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Kimberly-Clark Corporation (KMB) trades at 13. 2x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.
08Which pays a better dividend — HLN or CL or PG or CHD or KMB?
All stocks in this comparison pay dividends.
Kimberly-Clark Corporation (KMB) offers the highest yield at 5. 0%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).
09Is HLN or CL or PG or CHD or KMB better for a retirement portfolio?
For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
00), 2. 6% yield). Both have compounded well over 10 years (CL: +47. 0%, KMB: +12. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HLN and CL and PG and CHD and KMB?
These companies operate in different sectors (HLN (Healthcare) and CL (Consumer Defensive) and PG (Consumer Defensive) and CHD (Consumer Defensive) and KMB (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HLN is a mid-cap quality compounder stock; CL is a mid-cap quality compounder stock; PG is a large-cap quality compounder stock; CHD is a mid-cap quality compounder stock; KMB is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.